Mentions:
1: None It is rare for us to deny a redress payment, and we give feedback to the Scottish Government through - Speech Link

Report Jun. 10 2024

Found: fectively compete with other agencies within our sector that have more attractive packages, which is quite rare

Correspondence Jun. 10 2024

Found: a model can be found in the Police Ombudsman for Northern Ireland, internationally that is a very rare

Mentions:
1: Chapman, Maggie (Green - North East Scotland) In fact, it is very rare that one-off treatment is all that will be required.As Colin Smyth has outlined - Speech Link

Mentions:
1: Findlay, Russell (Con - West Scotland) , but the issue is whether there should be some form of appraisal of whether, in such a tribunal—as rare - Speech Link

Found: This is a specific, rare, type of land tenure found in Scotland; more background on this is set out in

Mentions:
1: Webber, Sue (Con - Lothian) activities to take place.For those who really want to talk about preventative spend, I want to speak about a rare - Speech Link

S6W-27429

Asked by: Briggs, Miles (Scottish Conservative and Unionist Party - Lothian)

Question

To ask the Scottish Government, further to the answer to the third supplementary to question S6O-03335 by Angela Constance on 24 April 2024, whether it can confirm if any non-crime hate incidents recorded by Police Scotland under the Hate Crime and Public Order (Scotland) Act 2021 will appear in any (a) disclosure and barring service check, (b) security clearance check, including a developed vetting check and (c) database check by (i) a serving officer or civil employee of Police Scotland and (ii) an employee of Disclosure Scotland, including an informal inquiry carried out with regard to current or potential employment.

Answered by Brown, Siobhian - Minister for Victims and Community Safety

In the Interim guidance published for officers on the recording of Non-Crime Hate Incidents - Police Scotland published by Police Scotland on 9 May 2024, it explains that the alleged perpetrator would usually be recorded as the ‘other party’ (unless in exceptional circumstances where there is real risk of harm or future criminal offence). When asked at the Scottish Police Authority Board Meeting on Thursday 23 May 2024 if detail on the ‘other party’ would appear on a Disclosure check, Deputy Chief Constable Alan Spiers provided reassurance that it would not.

In rare cases, Disclosure Scotland may receive other relevant information (ORI) from relevant police forces (including forces in England, Wales and Northern Ireland) when someone applies to join the PVG scheme, the ongoing monitoring of scheme members, or for an enhanced disclosure check.

ORI is used across the UK, with the UK Government having their own guidance to the police for the handling and processing of non-crime hate incidents in relation to disclosure checks. ORI about the applicant or scheme member can only be provided where the chief officer of a relevant police force reasonably believes it is relevant for the specific purpose of the disclosure and ought to be included on the disclosure certificate. The inclusion of any information Scottish police may hold on an individual is a decision for Police Scotland to make with regard to the statutory Guidance for the Chief Constable of Police Scotland.

Disclosure Scotland staff do not have access to the database on which non-crime hate incidents are recorded.

S6W-27622

Asked by: Choudhury, Foysol (Scottish Labour - Lothian)

Question

To ask the Scottish Government what medical advice it had received, regarding any risks of blood clots, prior to its decision to suspend the use of the AstraZeneca COVID-19 vaccine for under-30s in April 2021.

Answered by Minto, Jenni - Minister for Public Health and Women's Health

The Scottish Government’s decision-making throughout all COVID-19 vaccination programmes has been guided by the expert clinical advice of both the Joint Committee on Vaccination and Immunisation (JCVI) and the Medicines and Healthcare products Regulatory Agency (MHRA).

Scotland has three representatives that attend the JCVI, including its COVID-19 committee and subcommittee; one co-opted member, an invited observer from Scottish Government and another invited observer from Public Health Scotland.

The MHRA’s pharmacovigilance process, alongside wider global data, identified reports of extremely rare adverse events of concurrent thrombosis and thrombocytopenia following vaccination with the first dose of the AstraZeneca Covid-19 vaccine.

As reports of extremely rare adverse event of concurrent thrombosis (blood clots) and thrombocytopenia (low platelet count) following vaccination with the first dose of the AstraZeneca (AZ) COVID-19 vaccine emerged in spring 2021, both the MHRA and the JCVI met to assess the data and the relative balance of benefits and risks.

The minutes from the JCVI COVID-19 Committee on 16 March 2021 and 18 March 2021 show that there was discussion of the topic and that the MHRA was working with international and European colleagues to share data and assess the risk.

The JCVI met again on the 6 April and on 7 April and published advice for the four UK health departments recommending that for adults aged under 30 years of age, without underlying health conditions that put them at higher risk of severe COVID-19 disease, there should be a preference for an alternative to the AstraZeneca vaccine, if available.

The following day on 8 April, Scotland’s Chief Medical Officer (CMO) issued a letter to the Scottish system stating the changes in the use of AstraZeneca vaccine and advising that Health Boards should now offer those under 30 years of age, without underlying health conditions, an alternative to the AstraZeneca vaccine. We also amended our patient information leaflets to reflect this new advice.